June 07, 2022
3 min watch
Save
VIDEO: Results from SPOTLIGHT study ‘very exciting’
In this video, Mark T. Fleming, MD, discusses results from the SPOTLIGHT study, which he presented at this year’s American Urological Association meeting.
“It’s very exciting that we’re having a potential modality that really is able to find prostate cancer recurrence better than the conventional imaging that is out there,” Fleming, physician with Virginia Oncology Associates and national policy board chair for The US Oncology Network, said.
Reference:
- Fleming MT, et al. Impact of 18F-rhPSMA-7.3 PET on upstaging of patients with prostate cancer recurrence: Results from the prospective, phase 3, multicenter, SPOTLIGHT study. Presented at: American Urological Association meeting; May 13-16, 2022 (hybrid meeting).
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Fleming reports no relevant financial disclosures.
Read more about